FORMYCON AG (FYB.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:FYB - DE000A1EWVY8 - Common Stock
23.05 EUR
-0.4 (-1.71%)
Overall FYB gets a fundamental rating of 3 out of 10. We evaluated FYB against 85 industry peers in the Biotechnology industry. FYB has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, FYB is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
- FYB had negative earnings in the past year.
- In the past year FYB had a positive cash flow from operations.
- In multiple years FYB reported negative net income over the last 5 years.
- FYB had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- With a Return On Assets value of -22.86%, FYB perfoms like the industry average, outperforming 55.29% of the companies in the same industry.
- The Return On Equity of FYB (-41.58%) is better than 61.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -22.86% | ||
| ROE | -41.58% | ||
| ROIC | N/A |
ROA(3y)-1.19%
ROA(5y)-6.14%
ROE(3y)-0.68%
ROE(5y)-7.18%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- FYB does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- FYB does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, FYB has more shares outstanding
- Compared to 5 years ago, FYB has more shares outstanding
- Compared to 1 year ago, FYB has an improved debt to assets ratio.
2.2 Solvency
- FYB has an Altman-Z score of 0.49. This is a bad value and indicates that FYB is not financially healthy and even has some risk of bankruptcy.
- FYB has a Altman-Z score (0.49) which is comparable to the rest of the industry.
- FYB has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
- Looking at the Debt to Equity ratio, with a value of 0.02, FYB is in the better half of the industry, outperforming 74.12% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.49 |
ROIC/WACCN/A
WACC7.27%
2.3 Liquidity
- FYB has a Current Ratio of 1.54. This is a normal value and indicates that FYB is financially healthy and should not expect problems in meeting its short term obligations.
- The Current ratio of FYB (1.54) is comparable to the rest of the industry.
- FYB has a Quick Ratio of 1.51. This is a normal value and indicates that FYB is financially healthy and should not expect problems in meeting its short term obligations.
- The Quick ratio of FYB (1.51) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.54 | ||
| Quick Ratio | 1.51 |
3. Growth
3.1 Past
- The earnings per share for FYB have decreased strongly by -339.98% in the last year.
- FYB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.84%.
- FYB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.48% yearly.
EPS 1Y (TTM)-339.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-425.42%
Revenue 1Y (TTM)-14.84%
Revenue growth 3Y23.92%
Revenue growth 5Y15.48%
Sales Q2Q%0.03%
3.2 Future
- The Earnings Per Share is expected to grow by 48.97% on average over the next years. This is a very strong growth
- FYB is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.52% yearly.
EPS Next Y-42.25%
EPS Next 2Y39.02%
EPS Next 3Y48.97%
EPS Next 5YN/A
Revenue Next Year-8%
Revenue Next 2Y22.8%
Revenue Next 3Y31.02%
Revenue Next 5Y21.52%
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for FYB. In the last year negative earnings were reported.
- Also next year FYB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, FYB is valued cheaper than 96.47% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 3.47 |
4.3 Compensation for Growth
- FYB's earnings are expected to grow with 48.97% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.02%
EPS Next 3Y48.97%
5. Dividend
5.1 Amount
- FYB does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
FORMYCON AG / FYB.DE FAQ
What is the ChartMill fundamental rating of FORMYCON AG (FYB.DE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to FYB.DE.
What is the valuation status of FORMYCON AG (FYB.DE) stock?
ChartMill assigns a valuation rating of 2 / 10 to FORMYCON AG (FYB.DE). This can be considered as Overvalued.
What is the profitability of FYB stock?
FORMYCON AG (FYB.DE) has a profitability rating of 1 / 10.
How financially healthy is FORMYCON AG?
The financial health rating of FORMYCON AG (FYB.DE) is 3 / 10.
Can you provide the expected EPS growth for FYB stock?
The Earnings per Share (EPS) of FORMYCON AG (FYB.DE) is expected to decline by -42.25% in the next year.